To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain per
Proposal in Congress
- Introduced in House
Read the details
What this means
- Status
- Proposal in Congress
- Latest action
- Referred to the House Committee on Energy and Commerce.
- What to check next
- The bill was sent to the House Committee on Energy and Commerce for consideration.
Record details
- Bill number
- H.R. 1051
- Congress
- 119
- Introduced
- 2025-02-06
- Sponsor
- Rep. Budzinski, Nikki [D-IL-13]
- Committees
- Energy and Commerce Committee
- Latest documented action
- Referred to the House Committee on Energy and Commerce.
Documented actions
-
Referred to the House Committee on Energy and Commerce.
-
Introduced in House
-
Introduced in House
Sources and related records
Source checked .